3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
10
Unknown
1
Terminated
1
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
10
Thoracic
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
878
Pancreatic Neoplasms
572
Carcinoma, Hepatocellular
542
Stomach Neoplasms
512
Esophageal Neoplasms
312
Rectal Neoplasms
280
Colonic Neoplasms
254
Breast Neoplasms
203
Neoplasms
201
Liver Neoplasms
187
Lung Neoplasms
174
Carcinoma, Non-Small-Cell Lung
174
Cholangiocarcinoma
153
Ovarian Neoplasms
141
Neoplasm Metastasis
135
Gastrointestinal Neoplasms
133
Esophageal Squamous Cell Carcinoma
130
Melanoma
103
Prostatic Neoplasms
98
Biliary Tract Neoplasms
95
Endometrial Neoplasms
83
Uterine Cervical Neoplasms
79
Head and Neck Neoplasms
72
Squamous Cell Carcinoma of Head and Neck
69
Carcinoma, Renal Cell
58
Sarcoma
54
Adenocarcinoma Of Esophagus
54
Urinary Bladder Neoplasms
53
Anus Neoplasms
52
Triple Negative Breast Neoplasms
48
Interventions
pembrolizumab
1
Histamine H2 Antagonists
1
Famotidine
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Histiocytoma, Malignant Fibrous
×
Gastrointestinal
×
Clear all
NCT06789172
2026-05-22
INVOKE
Epkin
Phase 1
Recruiting
166 enrolled